S&P Equity Research downgrades Amgen (Nasdaq: AMGN) from Buy to Hold.

S&P analyst, S. Silver, says, "This reflects our ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE